Metoclopramide as an antiemetic agent in pediatric oncology patientsHOWRIE, D. L; FELIX, C; WOLLMAN, M et al.Drug intelligence & clinical pharmacy. 1986, Vol 20, Num 2, pp 122-124, issn 0012-6578Article

Vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum for advanced germ cell testis tumors: Brazilian experienceSROUGI, M; SIMON, S. D; MENEZES DE GOES, G et al.The Journal of urology. 1985, Vol 134, Num 1, pp 65-69, issn 0022-5347Article

Cours de chimiothérapie, Villejuif, 12-24 janvier 1987 = Lesson of chemotherapy, Villejuif, 12-24 January 1987Cours de chimiothérapie. 1987, 3Vol, pagination multConference Proceedings

Unresolved issues in combination chemotherapyWITTES, R. E; GOLDIN, A.Cancer treatment reports. 1986, Vol 70, Num 1, pp 105-125, issn 0361-5960Article

Treatment of acute lymphoid leukemia in children: current regimens and future prospectsBRECHER, M. L.New York State journal of medicine. 1986, Vol 86, Num 4, pp 188-196, issn 0028-7628Article

Thymic hyperplasia following successful chemotherapy: a report of two cases and review of the literatureCARMOSINO, L; DIBENEDETTO, A; FEFFER, S et al.Cancer. 1985, Vol 56, Num 7, pp 1526-1528, issn 0008-543XArticle

Commentaires sur l'approche thérapeutique du myélome = Comments on the clinical approach to myelomaPAULE, B; MEDICIS, P; CLERC, D et al.Revue du rhumatisme et des maladies ostéo-articulaires. 1986, Vol 53, Num 4, pp 269-274, issn 0035-2659Article

Has the MOPP era ended ?CANELLOS, G. P.British journal of cancer. 1991, Vol 63, Num 4, issn 0007-0920, p. 483Article

Methylthio-capping of selenocysteamine: preliminary studies on selective toxicity for cancer chemotherapyPIERSON, H. F; FISHER, J. M; RABINOVITZ, M et al.Research communications in chemical pathology and pharmacology. 1985, Vol 50, Num 3, pp 447-450, issn 0034-5164Article

Traitement de 1^re ligne = First line treatmentBUNEL, V; BERGHMANS, T.Revue des maladies respiratoires actualités (Print). 2014, Vol 6, Num 2, pp 121-125, issn 1877-1203, 5 p.Article

High-dose chemotherapy in solid tumours: a review of published data in selected tumours with a commentaryANTMAN, K. H; SOUHAMI, R. L.Annals of oncology. 1993, Vol 4, pp 29-44, issn 0923-7534, SUP1Conference Paper

Aplasie médullaire au cours d'une leucémie lymphoïde chronique traitée par polychimiothérapie mini-chopMAIGRE, M; LINASSIER, C; COLOMBAT, P et al.La Semaine des hôpitaux de Paris. 1992, Vol 68, Num 27-28, pp 786-789, issn 0037-1777Article

Empiric chemotherapy in patients with carcinoma of unknown primary siteSPORN, J. R; GREENBERG, B. R.The American journal of medicine. 1990, Vol 88, Num 1, pp 49-55, issn 0002-9343Article

Treatment of adult lymphoblastic leukaemiaJACOBS, P; WOOD, L; NOVITZKY, N et al.Haematology and blood transfusion. 1990, Vol 33, pp 428-431, issn 0171-7111Article

The contemporary management of Hodgkin diseaseHOPPE, R. T.Radiology. 1988, Vol 169, Num 2, pp 297-304, issn 0033-8419Article

La maladie de Hodgkin de l'enfant (à propos de 25 cas) = Childhood Hodgkin's disease (Report of 25 cases)CHEVALLIER, B; DEBBACHE, M. L; ZUCKER, J. M et al.Revue de pédiatrie (Paris). 1987, Vol 23, Num 2, pp 77-80, issn 0035-1644Article

Chemotherapeutic management of head and neck cancerMUHYI AL-SARRAF.Cancer metastasis reviews. 1987, Vol 6, Num 3, pp 181-198, issn 0167-7659Article

Prognostic and therapeutic advances in CLL management: the experience of the French cooperative groupSeminars in hematology. 1987, Vol 24, Num 4, pp 275-290, issn 0037-1963Article

Response to treatment and its influence on survival in metastatic breast cancerPATERSON, A. H. G; SZAFRAN, O; HANSON, J et al.American journal of clinical oncology. 1985, Vol 8, Num 4, pp 283-292, issn 0277-3732Article

The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California oncology group studyMEYERS, F. J; PALMER, J. M; FREIHA, F. S et al.The Journal of urology. 1985, Vol 134, Num 6, pp 1118-1121, issn 0022-5347Article

Alizapride: nouvel anti-émétique dans les vomissements graves au cours de la polychimiothérapie anti-cancéreuse à propos de 20 observations = Alizapride: a new anti-emetic for severe vomiting during anti-cancer polychemiotherapy (concerning 20 observations)TOURE, P; NDAO, D; WANDAOGO, A et al.Bulletin de la Société Médicale d'Afrique Noire de Langue Française. 1984, Vol 29, Num 2, pp 339-342, issn 0049-1101Article

ChlVPP : reducing toxicity in the treatment of Hodgkin's diseaseMANSI, J. L.European journal of cancer. Part A. 1992, Vol 28, Num 8-9, pp 1411-1413Conference Paper

Emesis and cancer chemotherapyALLAN, S. G; CHEYNE, A. J; WARRINGTON, P. S et al.European journal of cancer & clinical oncology. 1988, Vol 24, Num 3, issn 0277-5379, 503Article

No relevant influence on overall survival time in patients with metastatic breast cancer undergoing combination chemotherapyPETRU, E; SCHMÄHL, D.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 2, pp 183-185, issn 0171-5216Article

Effectiveness of attenuated chemotherapy in myelodysplastic syndromes: a preliminary reportOWENS, M. R; BENNETT, J. M.Medical and pediatric oncology. 1988, Vol 16, Num 2, pp 107-110, issn 0098-1532Article